相关实验视频
Updated: May 1, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.1K
原发性肺癌和转移的立体体辐射疗法:以案例为基础的关于挑战性病例的讨论
Colton Ladbury1, Baho Sidiqi2, Nate Cantrell3
1Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California.
Practical radiation oncology
|October 18, 2024
概括
肺瘤的立体体辐射疗法 (SBRT) 可以安全地应用于复杂的病例,包括超中心,多重或重新辐射的瘤. 仔细选择患者和多学科方法是优化挑战性肺SBRT治疗结果的关键.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 在瘤学瘤学.
背景情况:
- 立体体辐射疗法 (SBRT) 是早期非小细胞肺癌和肺转移的标准治疗方法.
- 现有的SBRT数据主要来自单独,有利位置的瘤患者.
- 将SBRT推断到更复杂的患者群体是积极研究兴趣的一个领域.
研究的目的:
- 为向具有挑战性的肺瘤病例提供SBRT的实践框架.
- 讨论SBRT用于超中心瘤,多重瘤和再辐射场景.
- 总结相关文献,用于治疗类似复杂的肺SBRT病例.
主要方法:
- 基于案例的讨论格式.
- 突出了肺癌中具有挑战性但常见的SBRT场景.
- 审查患者的特征,分量,剂量,技术和约束.
- 总结支持文献的内容.
主要成果:
- 治疗复杂的肺SBRT病例需要仔细考虑意图,分成,局部化和计划优化.
- 在具有挑战性的SBRT病例中,患者选择对于管理风险-益处概况至关重要.
- 交付技术和安全方面的进步为复杂场景提供了SBRT的支持.
结论:
- 开发了一个基于案例的指南,以解决常见的挑战性肺SBRT场景.
- 建议采用多学科的方法来处理这些复杂的案件.
- 优化治疗窗口对于最大化患者益处至关重要.
相关概念视频
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

